The ethics of telling: Alzheimer’s, diagnosis, and the power of communication
When it comes to Alzheimer’s disease, what we say – and how we say it – matters more than we might think. A new article
Read MoreWhen it comes to Alzheimer’s disease, what we say – and how we say it – matters more than we might think. A new article
Read MoreThe findings suggest a strategy to lower tau levels and explore the potential effects in Alzheimer’s disease and tau-induced dementias.
Read MoreThis study opens the door to potential new strategies to slow, reverse and treat neurodegenerative conditions.
Read MoreThe findings not only provide new insight into the factors regulating healthy memory but also in conditions associated with memory loss, like Alzheimer’s disease.
Read MoreThis work potentially contributes an important new piece of the puzzle regarding the development of Alzheimer’s disease.
Read MoreThe recent approval of Leqembi (lecanemab-irmb) by the U.S. Food and Drug Administration as a treatment for Alzheimer’s disease (AD) marks the first amyloid beta-directed
Read MoreThis approach, called Evolutionary Action Machine Learning, enables researchers to probe smaller cohorts with greater accuracy.
Read MoreThis post is a preview of a presentation for the Baruch A. Brody Lecture in Bioethics. Want to learn more about this topic? Tune into the lecture Feb.
Read MoreThis study highlights the importance of brain inflammation and other complex events involved in the development of Alzheimer’s disease.
Read MoreOleic acid produced in the brain is an essential regulator of the process that enables learning and memory and proper mood regulation.
Read More